Pular para o conteúdo
Merck
Todas as fotos(1)

Key Documents

View All Documentation

S-018

Supelco

Sufentanil-D5 solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C22D5H25N2O2S
Número CAS:
1884682-16-9
Peso molecular:
391.58
Número CE:
200-659-6
Código UNSPSC:
41116107
NACRES:
NA.24

grau

certified reference material

Nível de qualidade

300

forma

liquid

Características

Snap-N-Spike®/Snap-N-Shoot®

embalagem

ampule of 1 mL

fabricante/nome comercial

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

concentração

100 μg/mL in methanol

técnica(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

aplicação(ões)

forensics and toxicology

formato

single component solution

temperatura de armazenamento

2-8°C

cadeia de caracteres SMILES

[2H]C([2H])(C)C(=O)N(c1ccccc1)C2(CCN(CCc3cccs3)CC2)COC

InChI

1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3/i3D2

chave InChI

GGCSSNBKKAUURC-SMZGMGDZSA-N

Categorias relacionadas

Descrição geral

Sufentanil is a short acting synthetic opioid analgesic used as a painkiller during medical operations. This stable-labeled internal standard is suitable for quantitation of sufentanil levels in urine, serum, or plasma by LC/MS or GC/MS for clinical toxicology, pain prescription monitoring, forensic analysis, or isotope dilution methods. Sufentanil is sold under the trade name Sufenta.

Informações legais

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

produto relacionado

Nº do produto
Descrição
Preços

A-071

Alfentanil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-071

Pain Management Multi-component Opiate Mixture-13 solution, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

F-001

Fentanyl-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-002

Fentanyl solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-013

Fentanyl solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-030

Norfentanyl-D5 oxalate solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-031

Norfentanyl oxalate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-055

Norfentanyl-D5 oxalate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

S-008

Sufentanil Citrate solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

B-066

Butyryl fentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

C-162

Carfentanil Oxalate solution, (sold as 100 ug/mL in methanol as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-163

Carfentanil-D5 Oxalate solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-194

(±)-cis-3-Methylfentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-139

4-ANPP solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-049

p-Fluorofentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

I-038

Isobutyryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

N-114

Norcarfentanil oxalate oxalate salt solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-048

Valeryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-140

Acryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

O-047

Ocfentanil solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-048

p-Fluorobutyryl fentanyl (PFBF) solution, 100 μg/mL in methanol (), certified reference material, ampule of 0.5 mL, Cerilliant®

H-130

(±)-β-Hydroxythiofentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

D-168

N-Desmethyl U-47700-D3 solution, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

D-167

N-Desmethyl U-47700 solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

F-050

4-Fluoro-isobutyryl fentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

A-157

4-ANPP-D5 solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-054

o-Fluorofentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-200

Methoxyacetyl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-068

Valeryl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-177

Cyclopropyl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

F-053

Furanyl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-156

Acryl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

Palavra indicadora

Danger

Classificações de perigo

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Órgãos-alvo

Eyes

Código de classe de armazenamento

3 - Flammable liquids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

49.5 °F - closed cup

Ponto de fulgor (°C)

9.7 °C - closed cup

Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Harold S Minkowitz et al.
Regional anesthesia and pain medicine, 38(2), 131-139 (2012-12-29)
A sublingual sufentanil tablet is being developed as a potential alternative to intravenous (IV) opioids for the management of postoperative pain. The objective of these studies was to evaluate the pharmacokinetics, efficacy, and safety of sublingual sufentanil tablets for postoperative
C Jeleazcov et al.
British journal of anaesthesia, 109(5), 698-706 (2012-07-27)
Target controlled infusion (TCI) with sufentanil is usually performed using the Gepts model, which was derived from patients undergoing general surgery. It is, however, known that pharmacokinetics of sufentanil can be changed during cardiopulmonary bypass (CPB). We tested whether TCI
Q L Chen et al.
Acta anaesthesiologica Scandinavica, 57(2), 236-242 (2012-08-14)
Sufentanil is widely used in clinical anaesthesia because of its protective effects against ischaemia/reperfusion injury. Diabetes mellitus elevates the activity of glycogen synthase kinase-3β (GSK-3β), thereby increasing the permeability of mitochondrial transition pore. This study investigated the role of GSK-3β
Shen Sun et al.
Journal of anesthesia, 27(1), 25-28 (2012-08-28)
We aimed to investigate the effects of pretreatment with a small dose of dexmedetomidine on the cough caused by sufentanil during anesthetic induction. Two hundred and forty patients undergoing elective gynecological surgery under general anesthesia were randomly allocated to 4
S Dango et al.
British journal of anaesthesia, 110(3), 443-449 (2012-11-16)
Although thoracic epidural analgesia (TEA) is considered the gold standard for post-thoracotomy pain relief, thoracic paravertebral block (PVB) and intrathecal opioid (ITO) administration have also been shown to be efficacious. We hypothesized that the combination of PVB and ITO provides
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica